TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) /

The profitability of TEVA PHARMACEUTICAL INDUSTRIES LIMITED over the past 10 years

Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →

TEVA PHARMACEUTICAL INDUSTRIES LIMITED reported net income of $1.41B in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $8.94B and operating income of $2.16B. It reported a profit in 3 of the 10 years shown, and a loss in fiscal 2017, 2018, 2019, 2020, 2022, 2023 and 2024.

Year by year

Fiscal yearGross profitOperating incomeNet income
2025ended Dec 31, 2025$8.94B$2.16B$1.41B
2024ended Dec 31, 2024$8.06B-$303M-$1.64B
2023ended Dec 31, 2023$7.64B$433M-$559M
2022ended Dec 31, 2022$6.97B-$2.2B-$2.45B
2021ended Dec 31, 2021$7.59B$1.72B$417M
2020ended Dec 31, 2020$7.73B-$3.57B-$3.99B
2019ended Dec 31, 2019$7.54B-$443M-$999M
2018ended Dec 31, 2018$8.3B-$1.64B-$2.15B
2017ended Dec 31, 2017$10.62B-$17.48B-$16.27B
2016ended Dec 31, 2016$11.65B$2.15B$329M

Fiscal years as TEVA PHARMACEUTICAL INDUSTRIES LIMITED reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Companies of a similar size

Not investment advice. This page shows what TEVA PHARMACEUTICAL INDUSTRIES LIMITED filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.